Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia, USA.
Department of Neurosurgery, University of Louisville, Louisville, Kentucky, USA.
Neurosurgery. 2021 May 13;88(6):1111-1120. doi: 10.1093/neuros/nyab024.
Low-grade intracranial dural arteriovenous fistulas (dAVF) have a benign natural history in the majority of cases. The benefit from treatment of these lesions is controversial.
To compare the outcomes of observation versus intervention for low-grade dAVFs.
We retrospectively reviewed dAVF patients from institutions participating in the CONsortium for Dural arteriovenous fistula Outcomes Research (CONDOR). Patients with low-grade (Borden type I) dAVFs were included and categorized into intervention or observation cohorts. The intervention and observation cohorts were matched in a 1:1 ratio using propensity scores. Primary outcome was modified Rankin Scale (mRS) at final follow-up. Secondary outcomes were excellent (mRS 0-1) and good (mRS 0-2) outcomes, symptomatic improvement, mortality, and obliteration at final follow-up.
The intervention and observation cohorts comprised 230 and 125 patients, respectively. We found no differences in primary or secondary outcomes between the 2 unmatched cohorts at last follow-up (mean duration 36 mo), except obliteration rate was higher in the intervention cohort (78.5% vs 24.1%, P < .001). The matched intervention and observation cohorts each comprised 78 patients. We also found no differences in primary or secondary outcomes between the matched cohorts except obliteration was also more likely in the matched intervention cohort (P < .001). Procedural complication rates in the unmatched and matched intervention cohorts were 15.4% and 19.2%, respectively.
Intervention for low-grade intracranial dAVFs achieves superior obliteration rates compared to conservative management, but it fails to improve neurological or functional outcomes. Our findings do not support the routine treatment of low-grade dAVFs.
大多数情况下,低级别颅内硬脑膜动静脉瘘(dAVF)具有良性自然病史。这些病变的治疗获益存在争议。
比较观察与干预治疗低级别 dAVF 的结果。
我们回顾性分析了参与硬脑膜动静脉瘘结局研究(CONDOR)的机构中的 dAVF 患者。纳入低级别(Borden 1 型)dAVF 患者,并分为干预组和观察组。使用倾向评分对干预组和观察组进行 1:1 匹配。主要结局为最终随访时改良 Rankin 量表(mRS)评分。次要结局为优秀(mRS 0-1)和良好(mRS 0-2)结局、症状改善、死亡率和最终随访时的闭塞率。
干预组和观察组分别包括 230 例和 125 例患者。我们发现,在最后随访时(平均随访时间为 36 个月),未经匹配的两组之间在主要或次要结局上没有差异,除了干预组闭塞率更高(78.5% vs 24.1%,P<0.001)。经匹配的干预组和观察组各包括 78 例患者。我们也发现,在匹配的两组之间,主要或次要结局也没有差异,除了匹配的干预组闭塞率也更高(P<0.001)。未经匹配和匹配的干预组的手术并发症发生率分别为 15.4%和 19.2%。
与保守治疗相比,对低级别颅内 dAVF 进行干预可获得更高的闭塞率,但无法改善神经功能或功能结局。我们的研究结果不支持常规治疗低级别 dAVF。